Register | Login or

General Information

Websitenextechventure.com
Employees

Funds

Offices

Tags

Nextech Venture

Nextech Venture, located in Zurich, Switzerland, manages and advises two investment funds with a focus on healthcare. Nextech Venture’s Fund I is an early-stage venture fund focussing on European early-stage healthcare and information technology companies. With its unique oncology focused Fund II, Nextech Venture has become the world’s first dedicated investor for leading oncology companies in USA, Europe and Asia. Nextech Venture profits from the support of an active and committed Scientific Advisory Board of highly connected and influential scientific oncology advisors.

Nextech Venture organizes the Global Oncology Venture Event which is held annually in major cities around the globe.

Nextech Venture is independent from any other institution, be it financial, industrial or private. Is a member of the European Private Equity and Venture Capital Association EVCA and the Swiss Private Equity & Corporate Finance Association SECA.

Milestones

Investments

Company Date Round Size Participants
TetraLogic Pharmaceuticals 5/11Series C$6M1
Sunesis Pharmaceuticals 4/09Unattributed$43.5M9
Agensys 7/07Series D$41.3M8

Videos

Sources

  1. TetraLogic Closes $6 Million Series C-1 Investment with Nextech Invest Ltd (streetinsider.com) [edit]
  2. VCs PIPE $43.5 Million to Sunesis Pharma (pehub.com) [edit]
  3. Agensys Raises $41 Million (agensys.com) [edit]
Edit This Page
Last Edited 5/24/11

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy